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Freezing of gait (FoG) is a disabling symptom associated with falls, with little or no 
responsiveness to pharmacological treatment. Current protocols used for rehabilitation 
are based on the use of external sensory cues. However, cued strategies might generate 
an important dependence on the environment. Teaching motor strategies without cues 
[i.e., action observation (AO) plus Sonification] could represent an alternative/innovative 
approach to rehabilitation that matters most on appropriate allocation of attention and 
lightening cognitive load. We aimed to test the effects of a novel experimental protocol to 
treat patients with Parkinson’s disease (PD) and FoG, using functional, and clinical scales. 
The experimental protocol was based on AO plus Sonification. 12 patients were treated 
with 8 motor gestures. They watched eight videos showing an actor performing the same 
eight gestures, and then tried to repeat each gesture. Each video was composed by 
images and sounds of the gestures. By means of the Sonification technique, the sounds 
of gestures were obtained by transforming kinematic data (velocity) recorded during 
gesture execution, into pitch variations. The same 8 motor gestures were also used in 
a second group of 10 patients; which were treated with a standard protocol based on 
a common sensory stimulation method. All patients were tested with functional and 
clinical scales before, after, at 1 month, and 3 months after the treatment. Data showed 
that the experimental protocol have positive effects on functional and clinical tests. In 
comparison with the baseline evaluations, significant performance improvements were 
seen in the NFOG questionnaire, and the UPDRS (parts II and III). Importantly, all these 
improvements were consistently observed at the end, 1  month, and 3  months after 
treatment. No improvement effects were found in the group of patients treated with the 
standard protocol. These data suggest that a multisensory approach based on AO plus 
Sonification, with the two stimuli semantically related, could help PD patients with FoG 
to relearn gait movements, to reduce freezing episodes, and that these effects could be 
prolonged over time.
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inTrODUCTiOn
For decades, motor and gait difficulties have been identified 
as the main symptoms of Parkinson’s disease (PD), and drug 
therapy—based on dopamine and its agonists—was considered 
the only feasible solution to ameliorate symptoms. Amid these 
motor symptoms and gait abnormalities, freezing of gait (FoG) is 
the most debilitating; a sudden episodic inability to generate an 
effective stepping, which commonly, leads to falls.
However, PD is a complex neurological disease that comprises 
also severe psychiatric and cognitive symptoms. Today, the 
benchmark to treat PD symptoms, especially when they worsen, 
is the use of specific rehabilitation protocols together with medi-
cation and/or surgical therapy.
Drug therapy in PD is a symptomatic therapy, primarily aimed 
at restoring dopaminergic function in the striatum. Although 
irreplaceable in the treatment of PD symptoms, several data dem-
onstrate also negative effects, produced by dopamine on certain 
movements, and cognitive functions. Indeed, while dopaminergic 
medication clearly enhances certain motor functions, at the same 
time might negatively affect the learning of movement sequences 
(1, 2), as well as specific cognitive functions (3, 4). Moreover, the 
absent or controversial pharmacological responsiveness of FoG 
has led to an increasing interest in rehabilitation interventions 
aimed at functional recovery and autonomy, by relearning a 
physiological gait pattern.
Currently, protocols employed for rehabilitation of PD—with 
and without FoG—are based on the use of external sensory cues—
mainly visual, but also auditory and tactile—because it allows 
the switch from automatic movement (habitual)—controlled by 
frontostriatal pathways, that PD patients have compromised—to 
voluntary controlled movement [goal directed (5)]. Specifically, 
Vandenbossche et al. (6) showed that PD patients with FoG exhibit 
a specific impairment in the acquisition of automaticity—cor-
related with the working memory functions—and suggested that 
therapies should focus on training that reduce working memory 
load, as the cued strategies.
During exposure to visual and auditory cues, patients with 
FoG, as those without, improve gait kinematics and reduce freez-
ing. Interestingly, visual cues have more powerful effects than 
auditory cues for reducing FoG (7); proving that the inability to 
maintain effective scaling of step amplitude could be an impor-
tant FOG-related deficit. Conversely, auditory cues (metronome) 
seem to be less effective in the regularization of altered cadence, 
and disordered coordination of inter-limb movement in patients 
with FoG. Unfortunately, it has been shown that cueing might 
generate an important dependence on the environment, particu-
larly the visual ones, considering how important is the explora-
tion of the whole visual field in intentional walk (8).
In the last years, several researchers try to use cues differently. 
Young et al. (9) asked Parkinson’s patients with and without FoG 
to listen to different auditory cues (i.e., a metronome or ecologi-
cal footsteps sounds recorded on gravel), and to step in place to 
each cue, synchronizing their own stepping in time to the sound. 
Results in patients with FoG showed remarkable improvements 
in temporal regularity. The authors claim that in PD patients 
with FoG, the mechanism “action imitation enhances the motor 
performance” is supported by their results with action-relevant 
cues (i.e., footsteps recorded on gravel).
Teaching motor strategies, without cues to overcome or avoid 
freezing episodes can be an alternative/innovative approach 
to rehabilitation, that matters most on appropriate allocation 
of attention (10), and lightening cognitive load. One of these 
strategies—action observation (AO)—is based on the activa-
tion/sharing of a common neural substrate, the mirror system 
(11). The priming effect of AO on subsequent motor execution 
of the observed gesture is well known in neurorehabilitation, 
although few evidences are available for treatment of patients 
of PD (12).
Furthermore, one way to reduce cognitive load in the recovery/
learning of motor gestures is the use of multisensory approaches 
that enhance perceptual processes (13), which are known to be 
reduced in PD patients with FoG (14). The use of multisensory 
stimuli improves the learning process (13, 15) thanks to a reduced 
cognitive load, and to an easier storage in short-term memory 
(16, 17). But, to exert the most efficient facilitatory effect, pairs 
of stimuli composing the multisensory stimulus should be 
congruent, and not simply concomitant in space and/or time 
(18, 19). These findings have stimulated interest toward the use of 
audiovisual stimuli to facilitate relearning of movements also in 
the field of neurological rehabilitation.
Evidence on the efficacy of action-related sonified sounds 
(synthetized sounds obtained with a Sonification procedure, 
see the next paragraph) to improve motor performance is well 
documented [for a review, see Ref. (20)], although in PD patients 
is still limited. Indeed, Rodger et al. (21) used two different types 
of sounds (ecological and synthetized) to help guide and improve 
walking actions of PD patients. One of these techniques was based 
on Sonification of the ground reaction forces. Both methods 
showed that PD patients could use rich auditory representa-
tions of action to guide and improve the quality of walking, and 
reducing the risk of falls and injury. Moreover, Schmitz et al. (17) 
demonstrated that the Sonification of movements enhance the 
activity in the human AO system including subcortical structures 
of the motor loop; and therefore, may be an important method to 
enhance therapy effects in neurological rehabilitation.
The most natural way to use audio–video stimuli is to pre-
sent images together with ecological sounds (i.e., a walker and 
the sound of his/her feet). Instead of utilizing the real sounds 
produced during gait, we employed synthetized sounds obtained 
with the Sonification technique (22). Specifically, in our audio-
visual stimuli, the auditory component is obtained by transform-
ing kinematic data of relevant body part movements—visible 
in the video—into sounds. This process is called Sonification. 
We choose to use sonified sounds—in place of real sounds (i.e., 
footsteps sound)—because in this way we can convey additional 
information, important for the understanding and reproduction 
of a correct movement (i.e., differences in the velocity of the hips 
rotation during gait), that otherwise will be ignored. This final 
stimulus is a sort of augmented audio–video stimulus. The pro-
cessing of auditory and visual information together facilitates the 
recognition of the movement in its spatial and temporal aspects, 
and the relearning process of the correct pattern of movements. 
These stimuli could be of particular importance for PD patients 
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with FoG in which these components are altered, and in which, 
probably, visuo-perceptive modifications may be present (14).
We hypothesized that AO can be used to facilitate recovery 
of defective motor control, and given that PD patients with FoG 
may have major shortages of attention resources, a multisensory 
approach (i.e., audiovisual stimuli) would help to further reduce 
the attention load, facilitating learning processes.
The aim of this study was to test the efficacy of a novel protocol 
based on AO technique and Sonification, and to compare the 
effect with a standard protocol based on external sensory cues. 
With this purpose, we designed and realized an experimental 
study to test the effectiveness of these two protocols in two groups 
of PD patients with FoG. We hypothesized that gait improvement 
of the AO plus Sonification protocol would be better than those 
obtained with the standard protocol, both in the short term and 
the long term (3-month follow-up).
MaTErialS anD METHODS
Design
The whole pilot RCT was carried out from April 2015 to December 
2016. Post-intervention measures were collected at the end, 
1 month, and 3 months after the end of the treatment. Patients 
were randomly assigned to two different training group (experi-
mental and control groups). An investigator, neither involved 
in the treatment protocol nor in the selection and evaluation 
of patients, created the computerized randomization procedure 
(blocked randomization). The same investigator concealed treat-
ment allocation by using small opaque envelopes. Three trained 
physical therapists with a solid experience in the treatment of PD 
were involved in the evaluation—one of them—and in the treat-
ment of patients—the other two. Outcome measures were vide-
otaped and also evaluated by a second independent rater blind to 
the whole experimental study. In case of discrepancies between 
the two, a third blind rater was used to resolve the evaluation.
Patients were advised to have their medical treatment contin-
ued unchanged throughout the study. This study was carried out 
in accordance with the recommendations of the “Comitato Etico 
Regionale Unico” guidelines, with written informed consent from 
all subjects. All subjects gave written informed consent in accord-
ance with the Declaration of Helsinki. The protocol was approved 
by the Institutional Ethics Committee (Comitato Etico Regionale 
Unico—Friuli Venezia Giulia. Protocol no. 4456—05.02.2015). 
Patients who agreed to participate always signed a written 
informed consent and they were able to leave the experiment at 
any moment, with no additional explanations. The study has been 
registered at http://Clinicaltrials.gov, NCT03249155.
Participants
Thirty-seven patients with idiopathic PD (see Figure 1), accord-
ing UK Brain Bank (23) were assessed by a neurologist expert 
in movement disorders, from the outpatient Neurological Clinic, 
Cattinara Hospital. Eligibility criteria were occurrence of FoG 
(24) based on patient’s verbal account of his/her freezing experi-
ence (or recognition of their typical FoG experience when this 
symptom was described to him/her by a physician); stages 1–3 
on the Hoehn and Yahr scale (25); stable medication regimen 
for at least 8 weeks; no major depressive symptoms as defined by 
a Beck Depression Inventory score ≤16 [BDI (26)]; no signs of 
dementia as defined by a Mini-Mental Status Examination score 
>24 [MMSE (27)]. The exclusion criteria were evidence of any 
adjunctive orthopedic comorbidities that make it impossible to 
use physical activities and an independent locomotion; others 
neurological and psychiatric disease; presence of any implanted 
stimulating or pacing device in central nervous system. Prior 
power analysis estimated a sample size group of 10 participants. 
After the first assessment, we enrolled a total of 24 patients (see 
Figure  1). Two subjects dropped out due to concurrent, unre-
lated medical events: thus, 22 patients completed the study (see 
Table 1).
Experimental Procedures
All participants underwent to a 1  h of rehabilitation training 
during their ON condition (approximately 1 h after the antipar-
kinsonian medication intake), twice a week, for 8 consecutive 
weeks, and a total of 16 training sessions.
Experimental Group
The protocol was based on the AO method plus Sonification 
(AOS). During each training session, eight videos, showing an 
actor performing eight different motor gestures, were presented 
to the patient that then tried to repeat, according to the Modeling 
principles (28). Each video, lasting 1.5  min, was composed by 
images (from fronto-lateral perspectives) and sounds (obtained 
with Sonification) of eight specific motor gestures. These gait 
related gestures were useful for ameliorating weight shifting, 
step scaling, and bilateral coordination of stepping, known as 
locomotion features related to FoG. In each session, all videos 
were presented, from simple to complex motor actions. The con-
tents of the eight videos are reported in Appendix. Each session 
started with the observation of the audio–video projected on a 
large sized screen (2.5 m × 2 m) located in front of the patient at a 
distance of 2 m. During AO, to increase the accuracy of imitation, 
patients were asked to attend to the peculiar characteristics of the 
observed action, and no movements were allowed. At the begin-
ning, after video observation, patients had to practice repetitively 
the observed actions for the same time (1.5 min). Then, patients 
performed on line the same motor gesture while they were watch-
ing the videos. With the aim to facilitate the modeling process, 
an expert physiotherapist in AO treatment, encouraged and cor-
rected patient’s motor execution. Each video was repeated twice.
Control Group
The same eight motor gestures were performed also in the Cue 
control group with the same order and amount of time, by using 
attentional strategies. During each training session, patients were 
asked to practice the motor gesture by means of visual (stripes on 
the floor) or auditory (metronome) cues, to facilitate the learn-
ing of temporal and spatial parameters. As for the experimental 
group, the expert physiotherapist encouraged and corrected each 
patient’s motor execution to facilitate correct motor learning pro-
cess. Following physical therapist’s instructions, patients progres-
sively learned to perform the eight motor gestures without cues.
FiGUrE 1 | Flowchart showing the structure of the study, enrollment and evaluation procedure, and how the patients were divided into the groups, and phases.
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Participants of both groups were instructed to not practice 
further rehabilitation/physiotherapy treatments during the dura-
tion of the study. The two therapists involved in the treatments 
were not dedicated to one group, but equally assigned to both 
of them.
Clinical Outcomes
The patients who met inclusion/exclusion criteria underwent to 
a clinical and motor functional evaluation before the treatment 
(BT), after the treatment (AT), 1 month (1MFU), and 3 months 
AT (3MFU). The neuropsychological evaluations were only done 
at the baseline and 1  month (1MFU) AT, since the minimum 
interval for test administration is 3 months. All clinical evalua-
tions were performed by an experienced neurologist, and a physi-
otherapist blinded to participants’ allocation.
As primary outcome, FOG duration and severity were 
assessed by using New Freezing of Gait Questionnaire (NFOGQ). 
Particularly, we calculate an index of improvement obtained at 
AT, 1MFU, and 3MFU evaluations, respect to the BT evaluation 
(see Data Analysis).
A priori power analyses based on a previous experiment that 
compared the two treatment protocols in individuals with PD 
and FoG (29), suggested 10 participants per group to achieve a 
medium effect size (f = 0.45, alpha p = 0.05, power = 0.95, critical 
F = 4.41). We recruited 12 participants for each group to account 
for possible attenuation.
As for the secondary outcomes, disease severity was tested with 
the Unified Parkinson’s Disease Rating Scale (UPDRS II–III), the 
Hoehn and Yahr scale (25), and quality of life with the 39-item 
PD Questionnaire (30). Motor functional performance evaluation 
included Modified Parkinson’s Activity Scale (31), Timed Up and 
Go (32), and 6-min walking test (33). Berg Balance Scale (34) was 
used to assess static and dynamic balance capabilities. Also for the 
secondary outcome measures, we calculated an improvement index.
TablE 1 | Demographic and clinical characteristics of patients with Parkinson’s 
disease at baseline.
aOS group (n = 12) Cue group (n = 10)
Patients’ characteristics
Gender female/male (% female) 5/7 (42%) 3/7 (30%)
Age (years) 74.67 ± 5.93 72 ± 5.87
Disease duration (years) 10.75 ± 3.44 9.4 ± 4.86
Mini-Mental State Exam 27.46 ± 1.81 26.58 ± 1.1
Beck Depression Inventory 8 ± 5.98 6.4 ± 5.93
Hoehn and Yahr stage 2.33 ± 0.49 2.3 ± 0.67




UPDRS II Total 16.42 ± 5.99 17.1 ± 6.47
UPDRS III Total 32.92 ± 8.69 33.2 ± 13.99
MPAS 53.75 ± 6.27 50.2 ± 9.22
BBS 47.75 ± 4.16 47.8 ± 3.46
6MWT (s) 280.75 ± 93.34 296.75 ± 48.32
TUG (ms) 1,299.75 ± 376.74 1,271.3 ± 615.86
PDQ39 mobility 49.38 ± 22.54 35.5 ± 25.87
PDQ39 activities of daily living 33.4 ± 21.99 28.75 ± 17.84
PDQ39 emotional well-being 23.82 ± 21.84 33.33 ± 20.13
PDQ39 stigma 21.04 ± 22.94 18.75 ± 20.41
PDQ39 social support 2.78 ± 6.49 15.83 ± 22.03
PDQ39 cognitions 23.23 ± 15.52 31.88 ± 19.64
PDQ39 communication 24.31 ± 20.86 29.17 ± 21.25
PDQ39 bodily discomfort 31.67 ± 21.92 27.5 ± 19.27
PDQ39 Total 51.67 ± 26.9 50.8 ± 29.43
Data are mean ± SD or as otherwise indicated.
n, number of patients; NFOGQ, New Freezing of Gait Questionnaire; UPDRS, Unified 
Parkinson’s Disease Rating Scale II and III; PDQ39, Parkinson’s disease questionnaire 
39; MPAS, Modified Parkinson’s Activity Scale; BBS, Berg Balance Scale; 6MWT, 
6-min walking test; TUG, Time-Up-and-Go; PDQ39, 39-item PD Questionnaire.
TablE 2 | Cognitive profile of patients with Parkinson’s disease at baseline and at 1-month follow-up (1MFU).
Cognitive domain Test aOS group at baseline Cue group at baseline aOS group at 1MFU Cue group at 1MFU
Mean ± SD Mean ± SD Mean ± SD Mean ± SD
Short-term memory Digit Span Backward 4.84 ± 1.27 4.84 ± 1.14 4.59 ± 1.14 4.58 ± 1.02
Corsi Test 4.85 ± 0.84 4.34 ± 0.84 4.50 ± 0.83 5.01 ± 1.44
Long-term memory Babcock Story Recall Test
Immediate recall 5.78 ± 1.51 4.52 ± 2.48 5.27 ± 1.62 3.83 ± 2.50
Delayed recall 5.8 ± 1.4 4.41 ± 3.07 5.16 ± 1.88 3.41 ± 3.27
Attention Attentive Matrices 40.94 ± 8.35 32.46 ± 12.86 36.91 ± 11.27 31.56 ± 13.51
Trail Making Test:
Part A (s) 30.35 ± 21.59 68.51 ± 46.78 52.44 ± 45.98 55.27 ± 38.02
Part B (s) 147.34 ± 116.51 190.58 ± 130.99 148.35 ± 199.33 166.68 ± 117.38
Stroop Test
Time (s) 28.78 ± 19.19 52.73 ± 42.05 42.59 ± 26.17 47.72 ± 29.42
Errors 3.01 ± 3.55 1.83 ± 1.76 3.64 ± 2.47 3.36 ± 3.39
Executive functions Frontal Assessment Battery 16.7 ± 1.22 16.19 ± 1.71 16.55 ± 1.78 16.11 ± 1.80
Tower of London Test 17.99 ± 1.4 19.56 ± 6.38 18.61 ± 0.29 18.22 ± 1.41
Reasoning Raven’s progressive matrices 29.71 ± 6.18 27.28 ± 5.17 28.85 ± 6.16 27.70 ± 5.31
Data are mean ± SD or as otherwise indicated.
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profile of the patients of each group was changed after the end 
of the treatments. This was important to exclude that different 
levels of efficacy were due to differences in the cognitive profile 
of the two groups of patients. Global cognitive functioning was 
tested with the Montreal Cognitive Assessment (35); short-term 
and long-term memory functions with Digit Span backward 
(36), Corsi Test (37), Babcock Story Recall Test (38); attention 
with the Attentive Matrices (39), the Stroop Test (40), and Trail 
Making Test: parts A and B (41). Executive functions were 
evaluated with the Frontal Assessment Battery (42) and Tower 
of London Test (43). Abstract reasoning by Raven matrices (44). 
All neuropsychological tests scores were corrected on age, sex, 
and education using normative values. Moreover, patients were 
always tested in “ON” condition during their optimal antiparkin-
sonian medication.
audiovisual Stimuli
The short video used in the experimental group showed two 
healthy actors’ (one male and one female) performing the 8 motor 
gestures from a lateral and frontal perspective, for a total of 32 dif-
ferent videos (2 gender × 8 gestures × 2 perspectives). Moreover, 
prior rehabilitation treatment, and to be comfortable with the 
procedures, each participant practiced the tasks using other 
videos showing three movements test. The sounds of each video 
were obtained with the Sonification technique, by transforming 
kinematic data (i.e., velocity) recorded during the execution of 
the eight gestures, into audio pitch variations. Actors performed 
all tasks barefoot, walking along a 10-m walkway surrounded by a 
seven-camera motion-capture Qualisys System (120 Hz). During 
the execution of each motor gestures, kinematic data were col-
lected recording four retroflective markers placed on the left and 
right anterior superior iliac spine to calculate pelvis movement 
velocity, and on the left and right lateral malleoli to calculate 
inferior limbs velocity. All data were recorded and preprocessed 
by a dedicated software Qualisys Track Manager, and frame 
by frame instantaneous speed was obtained, and transformed 
Neuropsychological Evaluation
We assessed patients’ most important cognitive functions, useful 
for learning new motor ability: executive functions, attention, 
and memory capabilities (Table 2), to exclude that the cognitive 
TablE 3 | Split plot ANOVA results.
SS Mean sq F Pr(>F) η2G (%)
Main effect of treatment (Group)
Primary outcome measure
NFOGQ 2.741 2.741 24.28 0.000 50
Secondary outcome measures
PDQ39 mobility 12.630 12.633 14.91 0.001 38
UPDRSIII 4.962 4.962 13.36 0.002 33
PDQ39 bodily discomfort 4.962 4.962 13.36 0.002 33
PDQ39 Total 2.031 2.031 9.73 0.006 27
UPDRSII 1.427 1.427 11.14 0.003 24
BBS 0.121 0.121 6.42 0.020 24
6MWT 0.470 0.470 4.11 ns 15
TUG 1.070 1.071 3.95 ns 14
MPAS 0.021 0.021 0.56 ns 2
PDQ39 cognitions 0.471 0.471 0.47 ns 2
Main effect Time (within subjects)
Primary outcome measure
NFOGQ 0.091 0.046 3.11 ns 3
Secondary outcome measures
PDQ39 mobility 0.151 0.075 0.60 ns 1
UPDRSIII 0.334 0.167 2.14 ns 3
PDQ39 bodily discomfort 0.334 0.167 2.14 ns 3
PDQ39 Total 0.158 0.079 2.05 ns 3
UPDRSII 0.049 0.025 0.48 ns 1
BBS 0.005 0.003 3.01 ns 1
6MWT 0.061 0.031 2.91 ns 2
TUG 0.222 0.111 3.66 0.035 3
MPAS 0.009 0.005 0.69 ns 1
PDQ39 cognitions 1.546 0.773 4.17 0.023 6
interaction effect (Time × Group)
Primary outcome measure
NFOGQ 0.002 0.001 0.07 ns 0
Secondary outcome measures
PDQ39 mobility 0.386 0.193 1.54 ns 2
UPDRSIII 0.197 0.098 1.26 ns 2
PDQ39 bodily discomfort 0.197 0.098 1.26 ns 2
PDQ39 Total 0.261 0.131 3.41 0.043 5
UPDRSII 0.047 0.023 0.46 ns 1
BBS 0.002 0.001 0.90 ns 0
6MWT 0.022 0.011 1.03 ns 1
TUG 0.034 0.017 0.56 ns 1
MPAS 0.014 0.007 1.02 ns 1
PDQ39 cognitions 0.451 0.225 1.22 ns 2
ns, not significant; NFOGQ, New Freezing of Gait Questionnaire; UPDRS, Unified 
Parkinson’s Disease Rating Scale II and III; PDQ39: Parkinson’s disease questionnaire 
39; MPAS, Modified Parkinson’s Activity Scale; BBS, Berg Balance Scale; 6MWT, 
6-min walking test; TUG, Time-Up-and-Go; PDQ39, 39-item PD Questionnaire; SS, 
sum of squares.
UPDRSIII, TUG, PDQ39 mobility, and PDQ39 bodily discomfort were log transformed 
for normality. Index η2G is the generalized eta-squared statistics calculated following 
the guidelines by Olejnik and Algina (48) and Bakeman (49). For the two main effects 
and interaction tested we used the formulas SSA/(SSA + SSs/A + SSPs/A), SSP/
(SSP + SSs/A + SSPs/A) and SSPA/(SSPA + SSs/A + SSPs/A), where A and P refer 
to our variables Group and Time, respectively, and s represents the subject factor. 
Errors related SS are not shown in this table.
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into pitch audio by the open source framework Pd (45) using 
modules developed by Henkelmann and colleagues (46, 47). The 
Sonification itself is done in the following steps: first, median filter 
with a window size of three frames is applied to the kinematic data 
to suppress sensor noise from the kinematic data. Second, the 
data stream is linearly scaled to an interval from 0 to 1. Third, the 
pitch sound itself is generated. Forth, the sound is mapped to 
the left or right audio channel. The PD module we used to gener-
ate our stimuli can be found in the supplemental materials for 
this publication. 32 audio track were gained (2 actors gender × 8 
different gestures × 2 perspectives) for each motor gestures, and 2 
audio tracks for each movement test. Videos were edited by using 
Final Cut Pro X software, with a dubbing procedure to merge 
the sounds with the video part of each gesture. The kinematic–
acoustic recording was provided with a visual auditory stimulus 
congruence.
Data analysis
Preliminary, applying the Kolmogorov–Smirnov (KS) test we 
verified the sustainability of a normal distribution for the primary 
and secondary clinical outcomes. Highly skewed and kurtotic 
variables were log transformed and then KS tested for the effec-
tiveness of the correction. Outcomes that failed this second test 
where excluded from the analysis.
For each clinical outcome, the improvement (gain) from pre-
training to posttraining (AT, 1MFU, and 3MFU) was computed 
for each participant by subtracting each person’s pretraining score 
from his/her posttraining score and dividing the difference for 







Systematic differences in pretraining scores between the two 
groups of patients were preliminary excluded with t-tests on both 
primary and secondary outcomes measures. As for the cognitive 
profile, we verified for potential differences in the pretraining 
(BT) and modification after 3 months (1MFU) with a 2 × 2 mixed 
factors ANOVA (Group and Time of evaluation). The results are 
reported in Table 3.
The hypothesis of differences in improvement (gain) between 
the experimental and control groups was tested by a mixed design 
ANOVA on the gain scores using Group (AOS vs. Cue) as a between 
subjects factor, and Time of evaluation as within-subject factor. 
Besides main effects, we also considered the interaction terms 
Group × Time to assess the stability of the effect across evalua-
tion. Post hoc Bonferroni’s test was employed to assess gain score 
differences between groups at each time. The significant change 
threshold was set at p ≤  0.05. We interpreted the meaningful-
ness of the significant changes using the generalized eta-squared 
(η2G) statistics calculated following the guidelines by Olejnik and 
Algina (48) and Bakeman (49).
Linear Discriminant Analysis (LDA)
Besides these statistical criteria, to examine the clinical impact 
of the AOS and Cue training on outcomes scores, we used also 
an automated classification rates criterion. This method is com-
monly used as a technique for pattern classification. In our case, 
we used this method to compare or classify the clinical profiles of 
the patients in the two groups, and at the different stages of the 
experimental study. Automated classification problems involve 
continuous input variables (i.e., our clinical scales), and categori-
cal outcomes (i.e., the rehabilitation protocol or the stage of the 
study). The algorithm has to learn to predict the category from 
the input data. We used an LDA algorithm in two differ ways, 
FiGUrE 2 | Improvement (gain) of the two groups in the primary outcome 
measure [New Freezing of Gait Questionnaire (NFOGQ)], at the three 
evaluation times. Error bars are 1 SE.
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to discriminate between groups and within subjects. Finally, we 
choose to complement standard analysis of variance with this LDA 
because of recommendations on using simulative approaches to 
data analysis with small samples (50).
First, the algorithm learned between-groups’ discriminative 
criterion on a fraction of 70% of the data set, then for testing 
we applied the criterion on the remaining fraction of 30% (see 
Supplementary Material), measuring the classification accuracy 
in terms of sensitivity index (51). Average sensitivities were based 
on a complete random design, simulating all possible combina-
tion of 70–30% of the participants (50). Particularly, we trained 
and tested the LDA four times, over each evaluation time (BT, AT, 
1MFU, and 3MFU), and considering the rehabilitation protocol 
attended by participants as the categorical outcome to predict.
Second, to evaluate stability over time, as in the case of interac-
tion term in the ANOVA, we considered within-subject evalua-
tions, using the LDA algorithm on a subset composed by 70% of 
pre- and posttraining individual’s outcomes, and testing it on the 
remaining 30% of pre- and posttraining individual’s outcomes.
In both cases, we expect that the more effective is the training 
in transforming the participants clinical profile, the more accurate 
is the LDA algorithm in (learn to) classify the participants within 
the training actually practiced. In the first LDA implementation, 
we expect that the LDA classification would fail only in the com-
parison between the two groups at the BT time window.
All the analyses were programmed using R statistical lan-
guage (52).
rESUlTS
At the baseline, there were no significant differences between 
groups with respect to demographics and clinical records, as shown 
in Table 1. Also for the cognitive profile, as reported in Table 2, 
there was no differences except for the interaction Group × Time 
in the Corsi test [F(1,20) = 5.975, p = 0.024, η2 = 0.225], but when 
we compared the two groups in the two moments with a t-test, 
the difference was not significant [t(20)  =  1.449, p  =  0.163; 
t(20) = −0.480, p = 0.636].
Primary Outcome Measure
Action observation plus Sonification treatment had a significant 
positive effect in reducing the primary outcome measure, partici-
pant’s ratings of FoG severity and duration, as shown at the end 
of the treatment, and most important, at the second follow-up 
(Figure  2, NFOGQ). Noteworthy, on our sample the standard 
Cue protocol did not show any relevant gain effect from the 
baseline evaluation.
Secondary Outcome Measures
Secondary outcome measures that improved in AOS (Figure 3) 
were as follows: severity of motor impairment (UPDRS III); 
motor problems, and bodily discomfort in activity of daily life 
(the mobility and bodily discomfort subscales of the PDQ39 
questionnaire). For this pool of outcome measures, the positive 
effect of AOS treatment over Cue training has a great effect size 
(η2G > 0.30) and is stable until the last follow-up (see post hoc 
comparisons reported in Table 4). Even in these measures, the 
standard Cue protocol did not show any relevant gain effect. 
Figures 2 and 3 show the gain scores of the main effects.
Table 3 reports F-tests for main effects and interaction sepa-
rately, for all outcomes considered, whereas Table 4 reports direct 
comparisons at each evaluation time, between groups.
At first glance, for nearly all secondary outcomes, the group 
factor (the main effect of rehabilitation protocol) had the greater 
effect size (η2G). These effects are stable over time since interac-
tion terms are not significant and/or with negligible amounts of 
variance explained.
The problems in activity of daily living (PDQ39 total score, 
UPDRS II) were significantly reduced by AOS training, with 
stable results also after 3 months. Moreover, AOS training deter-
mined also a small improvement on average gain scores of motor 
balance (BBS, see Tables 3 and 4).
linear Discriminant analysis
We trained an LDA algorithm to learn to discriminate between 
rehabilitation protocols attended by participants, using as input 
variables significant outcomes identified by ANOVA. Particularly, 
inclusion criteria were the following: (a) significant main effect 
on group factor and great effect size (>0.30), (b) stable result 
over evaluation time (no interaction in Table 1 and significant 
post hoc comparisons in Table 3). Input variables were the raw 
data, not transformed into gain scores. Figure 4A shows average 
discrimination accuracy, expressed in terms of sensitivity—i.e., 
SDs from chance (51). At the baseline, the algorithm could not 
FiGUrE 3 | Improvement (gain) of the two groups in five secondary outcome measures [Unified Parkinson’s Disease Rating Scale: parts II and III (UPDRS) and 
Parkinson’s disease questionnaire 39 (PDQ39): mobility, bodily discomfort, and the total score], at the three evaluation times. Error bars are 1 SE.
8
Mezzarobba et al. AO Plus Sonification Therapeutic Protocol
Frontiers in Neurology | www.frontiersin.org January 2018 | Volume 8 | Article 723
learn a reliable criterion to recognize “AOS” or “Cue” participants 
since their clinical profiles are homogeneous (Table 2) and hence 
its performance stops to a chance level. Immediately AT, at 
1 month, and after 3 months, experimental protocol differentiates 
participant’s outcomes from the baseline levels and the algorithm 
can learn a criterion that move the performance (nearly) 1 SD 
from the chance. Importantly, the effect is far more evident con-
sidering the mobility outcome (NFOGQ and UPDRS III), over 
the improvement in ability of daily activities (PDQ39 mobility 
and bodily discomfort).
Furthermore, using the same input variables, we trained an 
LDA algorithm to discriminate each participant’s pre- and post-
training conditions, within each group; Figure 4B shows average 
sensitivity index, separately for the AOS and Cue conditions. 
Participants trained with experimental AOS protocol were dis-
criminable with respect to their baseline condition to an extent 
of 2 SD from chance, using clinical motor profile, and this result 
is quite stable over time. The ability of the algorithm to learn 
systematically a criterion over the chance was not proven, within 
participant’s undergoing rehabilitation with Cue.
DiSCUSSiOn
Sonification and AO are used together for the first time with the 
aim to treat motor diseases in PD patients with FoG. The main 
finding of our study is that this multisensory treatment reduces 
FoG (number of episodes and duration), and provided positive 
effects on gait pattern in short- and long-term period.
These results are in agreement with those obtained in two 
previous studies with the use of AO: Pelosin et al. (29) and Agosta 
et al. (53). In both these studies, freezing improvements (assessed 
with FOGQ and NFOGQ, respectively) were evaluated only up 
to 1 month after the end of the treatment—instead of three—and 
with mixed and weak results—Pelosin’s data showed a significant 
improvement at the 1-month follow-up, but not at the end of the 
treatment, and the reverse pattern in the Agosta’s. Our data with 
FiGUrE 4 | Average discrimination accuracy expressed in terms of sensitivity 
(d′) of the linear discriminant analysis (LDA) algorithm. (a) Results of testing 
between-groups’ discrimination. Dark gray bars represent LDA results from 
the New Freezing of Gait Questionnaire (NFOGQ) and UPDRS III scales. Light 
gray bars represent LDA results from the PDQ39 mobility and bodily 
discomfort scales. (b) Results of testing within-subject discrimination. Dark 
and light red bars represent LDA results from the NFOGQ and UPDRS III 
scales for the Action Observation plus Sonification experimental group. Dark 
and light blue bars represent LDA results from the PDQ39 mobility and bodily 
discomfort scales, for the Cue control group.
TablE 4 | Bonferroni post hoc comparisons AOS group vs. cue group.
after treatment 1st Follow-up 2nd Follow-up
Primary outcome measure
NFOGQ p ≤ 0.001 p ≤ 0.001 p ≤ 0.001
Secondary outcome measures
PDQ39 mobility p ≤ 0.05 p ≤ 0.001 p ≤ 0.001




PDQ39 Total ns p ≤ 0.01 p ≤ 0.01
UPDRSII ns p ≤ 0.05 p ≤ 0.01
BBS ns p ≤ 0.05 ns
6MWT ns ns p ≤ 0.05
TUG ns ns ns
MPAS ns ns ns
PDQ39 cognitions ns ns ns
Data are p-levels of the direct comparisons at each evaluation time, between groups, 
after the Bonferroni correction.
NFOGQ, New Freezing of Gait Questionnaire; UPDRS, Unified Parkinson’s Disease 
Rating Scale II and III; PDQ39, Parkinson’s disease questionnaire 39; MPAS, Modified 
Parkinson’s Activity Scale; BBS, Berg Balance Scale; 6MWT, 6-min walking test; TUG, 
Time-Up-and-Go; ns, not significant.
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AO plus Sonification showed consistent and significant effects in 
several of the secondary outcome measures: on motor impair-
ment (UPDRS III), and quality of life (PDQ39 mobility scale), 
during the entire 3-month period of evaluation; while balance 
(BBS), gait parameters (6MWT), only at the first and second 
follow-up, respectively. Overall, our data confirmed the thera-
peutic potential of a protocol based on AO plus Sonification in 
treating gait disorders and FoG. In AOS group, patients improved 
their mobility, acquiring new motor strategies to overcome FoG, 
and these effects are prolonged over time and generalized to FoG 
in daily life.
In Cue control group, no enhancements were found for all 
mobility indices, throughout the three testing times. Only data in 
PDQ39 questionnaire subitem mobility and activities daily living 
show trend values toward an improvement, that with a larger 
sample, could lead to significance. A possible explanation is a 
residual cue dependence effect, which may have not triggered an 
effective learning process (54), and pointing out that evidences on 
the effectiveness of cue trainings in the alleviation of FoG symp-
toms is still a hot topic. Another potential factor could be the 
age of our sample. Although the two groups were not statistically 
different in age and stage of the disease, overall our patients were 
quite old (73 years). Probably, older patients may require a more 
specific training to engage a motor consolidation process when a 
standard protocol based on external sensory cues is used. Indeed, 
it should be emphasized the lower mean age of participants with 
PD and FoG in previous studies [66  years—Agosta et  al. (53); 
66 years—Lu et al. (55); 62 years—Young et al. (9)], when com-
pared with the ones of our research. This age difference could 
have produced an additional decline in motor learning (56). In 
a crossover design with old patients with PD and FoG (mean 
age, 74 years), Bunting-Perry et al. (57)—using a laser beam on 
a rolling walker as a visual cue—showed no significant effects in 
diminishing FoG and improving walking.
The peculiar feature and novelty of our approach is the inclu-
sion of a sonified audio track—representing kinematic features 
of a movement—to the video of the same movement. In other 
words, we used the Sonification to highlight task-intrinsic (spatial 
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and temporal) information, otherwise difficult to access. This aug-
mented stimulus is very different from those typically employed 
in AO treatments, since usually the sound part is absent (29), or 
not related in meaning to the content of the video [not congruent 
multisensory stimulus as in Ref. (53)]. When a patient attends to 
a stimulus with a sound cue (i.e., metronome) presented together 
with a video of an action, the amount of cognitive resources 
necessary to integrate the information of the two stimuli—not 
related in meaning—increase [for a review, see Ref. (58)]. In our 
protocol, the videos are congruent multisensory stimuli, in the 
sense that sounds and images are related in meaning, and prob-
ably bound together at the perceptual level. This conclusion is 
based on patients’ personal reports; they all reported to perceive 
stimuli as being highly consistent, and treated them as a single 
audiovisual event [the unity assumption—for a recent review, see 
Ref. (59)]. In fact, during the training, we did not need to use 
any particular type of instruction—except that the sound simply 
derived from the velocity of the movement—to let patient under-
stand the meaning of sonified sounds, and the relation between 
the two sources of information (sound and image). After the 
presentation of the examples, the meaning of the stimuli became 
clear to almost all patients, and for those with some doubts, the 
presentation of the first stimulus was sufficient to understand.
The observation of action activates in humans the mirror neu-
ron system (MNS) within the premotor cortex, inferior frontal 
gyrus, and inferior parietal lobule, that maps sensory signal onto 
the same neural circuits involved in motor planning and execu-
tion of the observed motor gesture. Congruent Sonification may 
have improved AO priming effect on movement. Indeed, during 
congruent audiovisual stimuli observation, Schmitz et al. (17) 
demonstrated an amplified activation of some of the major MNS 
areas, particularly frontal operculum, inferior parietal lobule 
and the superior temporal areas. Thanks to an enhanced per-
ceptual analysis of the movement, congruent Sonification could 
lead to an improved neural representation of the observed motor 
action, and to an easier learning process thanks to a lightened 
cognitive load.
Motor learning involves the interaction of several compo-
nents (60): extraction and processing of task-relevant sensory 
information, making decision aimed to define which movements 
to perform (and in which order), activating control processes, 
and finally a reactive and biomechanical control. A multisensory 
AO plus Sonification protocol might have aided the first phase 
of motor learning, facilitating the extraction and integration of 
visual and coherent auditory inputs, for a better understanding 
of spatial and temporal features of motor action.
Moreover, we hypothesize that our multisensory protocol—
based on congruent and unitary stimuli—could have produced 
positive effects on memory, and specifically working memory 
processes. In fact, Lehmann and Murray (15) showed that 
semantically congruent multisensory stimuli can enhance subse-
quent processing and memory performance, and more recently 
Brunetti et al. (61) demonstrated that crossmodal correspondence 
(i.e., audiovisual congruent stimuli) produced faster reaction times 
and higher accuracy in a classical working memory task (n-back 
task). Given these findings, and given that PD patients are known be 
impaired in working memory processes [see, for example, Ref. (62)], 
the use of multisensory stimuli could have facilitated the pro-
cessing and consequently the production of more effective gait 
patterns.
Sonification, as alternative, can be used in a rehabilitation 
program for patient with PD by generating additional real-time 
movement information, being suitable for integration with visual 
and proprioceptive perceptual feedback, while the patient is 
performing physical exercises. With ongoing training activity, 
synchronously processed auditory information should be initially 
integrated into the emerging internal models, enhancing the 
efficacy of motor learning. This is achieved by a direct mapping of 
kinematic and dynamic motion parameters to electronic sounds, 
resulting in continuous auditory and convergent audiovisual or 
audio-proprioceptive stimulus arrays.
A critical analysis of protocols’ features emphasize that learning 
strategies used in the two groups could be also partially different 
in terms of learning mechanisms. Indeed, they are more related to 
a modeling process—with movement-related analogic represen-
tations—in the experimental group, while in the control group 
followed a cueing approach—with abstract and propositional 
representations. Agosta et  al. (53) used a similar experimental 
design with a control group that underwent to a motor learning 
process by instructions and an experimental group that improved 
motor action by AO. In our control group, we used visual and 
auditory cue whose effectiveness had already been stressed by 
several studies in PD patients with FoG, and these results could 
be also considered as a further confirmation of the effectiveness 
of the AO therapy.
The combination in our AO plus Sonification protocol of a 
multisensory and analogic approach instead of a unisensory and 
abstract approach, produced promising positive effects, although 
we cannot evaluate nor the relative impact of each component, 
neither the effect of their interaction. However, this matter 
remains to be fully address.
Finally, as for the long-lasting effects, our protocol was a not 
intensive 8-week training program, which is not a long rehabilita-
tive period from a motor learning and physical exercise perspec-
tive. Nevertheless, given that our results showed both immediate 
(upon the end of treatment), and long-term retention (3 months 
following cessation of treatment) of gait improvement, we may 
suppose that these benefits can be explained with a neuroplas-
ticity process induced by goal-based exercises (63). As reported 
in previous studies (63, 64), goal-based exercise can promote 
neuroplasticity effects, which have been demonstrated in several 
neurological conditions, and also in PD, through changes in 
cortical excitability and cortical representation. Recently, using 
fMRI, Agosta et al. (53) demonstrated AO-related performance 
enhancement in patients with PD and FoG was possible with an 
intensive 4-week training program (12 sessions) and was associ-
ated with an increased activation of motor cortical areas and 
fronto parietal regions of the MNS.
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This study was carried out in accordance with the recommenda-
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written informed consent in accordance with the Declaration of 
Helsinki. The protocol was approved by the Institutional Ethics 
Committee (Comitato Etico Regionale Unico—Friuli Venezia 
Giulia. Protocol no. 4456—05.02.2015). Patients who agreed 
to participate always signed a written informed consent and 
they were able to leave the experiment at any moment, with no 
additional explanations. The study has been registered at http://
Clinicaltrials.gov, NCT03249155.
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Exercise 1
Shifting the body weight in the frontal plane and taking a step—
Actor stands straight up, with both feet on the floor, shifting the 
body weight to the right (or to the left), to the left (or to the right), 
and then raise and move forward the right (or the left) leg and the 
body to take the first step.
Exercise 2
Shifting the body weight in the sagittal plane and taking a step—
Actor stands straight up with both feet on the floor. One foot 
placed in front of the other, with the heel ahead of the other foot’s 
toes. The actor shifts weight from one foot to the other, always 
keeping the feet on the floor; afterwards he takes a step forward.
Exercise 3
Gait initiation—Actor starts to walk with the preferred leg.
Exercise 4
Turning around—Actor walks two steps with a straight trajectory, 
and then made a 180° turn in a narrow quarter (U-turn).
Exercise 5
Stepping over an obstacle—Actor walks three steps with a straight 
trajectory, and then steps over the obstacle (obstacle’s height: 10% 
of patient’s height).
Exercise 6
Sit-to-walk—Actor is seated on a backless and armless stool (knee 
angle 100°), and then raises and walks three steps forward.
Exercise 7
Walking straight with long steps—Actor walks about 10 long 
steps with a straight trajectory trying to maintain a steady pace 
and to take long steps.
Exercise 8
Walking through a doorway—Actor walks three steps with a 
straight trajectory, moves through a real doorway without stop-
ping and then continue to walk two more steps.
